A survey indicates that one in eight U.S. adults have taken weight-loss drugs like Ozempic, but over 30% discontinue use within four weeks. Unpleasant side effects, such as nausea and digestive issues, are common, while severe conditions like pancreatitis have been linked to prolonged use. Since the drugs' introduction, new side effects have emerged, prompting concern among medical professionals. Ozempic was approved for diabetes treatment in 2017, followed by Wegovy in 2021 for weight loss, with clinical trials initially showing their safety; however, additional adverse reactions are now more frequently reported.
More than 30% of adults taking weight loss drugs like Ozempic drop the medication after just four weeks, leading to concerns about their effectiveness.
Ozempic and its equivalent Wegovy have been linked to multiple unpleasant side effects, including nausea, digestive issues, and more severe conditions like pancreatitis.
Reports have emerged of severe medical illnesses after prolonged use of GLP-1 drugs, raising alarms among medical professionals about their long-term safety.
Clinical trials initially deemed GLP-1 drugs safe, but new side effects have been reported since their release to the public, including rare adverse reactions.
Collection
[
|
...
]